155 related articles for article (PubMed ID: 37528150)
21. Long noncoding RNA LINC00629 restrains the progression of gastric cancer by upregulating AQP4 through competitively binding to miR-196b-5p.
Li J; Wang L; He F; Li B; Han R
J Cell Physiol; 2020 Mar; 235(3):2973-2985. PubMed ID: 31674022
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R.
Zhang Z; Zhao M; Wang G
J Cell Physiol; 2019 Dec; 234(12):22195-22206. PubMed ID: 31102265
[TBL] [Abstract][Full Text] [Related]
23. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer.
Li L; Wei D; Zhang J; Deng R; Tang J; Su D
Comput Math Methods Med; 2022; 2022():5203839. PubMed ID: 35069784
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Liu X; Ma W; Ma J; Xiao L; Hao D
Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract][Full Text] [Related]
26. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
27. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
28. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma.
Ye P; Ke X; Zang X; Sun H; Dong Z; Lin J; Wang L; Liu W; Miao G; Tan Y; Tong W; Xiao H; Gao L
Biomed Pharmacother; 2018 May; 101():219-227. PubMed ID: 29494959
[TBL] [Abstract][Full Text] [Related]
29. MiR-361-3p promotes tumorigenesis of osteosarcoma cells via targeting ARID3A.
Zhou D; Ji G; Wei G; Li Z; Yu N; Wang Y; Lin B; Zhang L; Yin Y
Tissue Cell; 2022 Jun; 76():101759. PubMed ID: 35219069
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
Duan N; Hu X; Yang X; Cheng H; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733
[TBL] [Abstract][Full Text] [Related]
31. LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128.
Xu Q; He L; Ma L; Fan L; Yan L; Zhao X; Li Y
Aging (Albany NY); 2020 Dec; 12(24):24957-24966. PubMed ID: 33401246
[TBL] [Abstract][Full Text] [Related]
32. lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7.
Xue Y; Liu H; Nie G; Ren X
Dis Markers; 2022; 2022():4660217. PubMed ID: 35422889
[TBL] [Abstract][Full Text] [Related]
33. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
[TBL] [Abstract][Full Text] [Related]
34. miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9.
Wang WT; Qi Q; Zhao P; Li CY; Yin XY; Yan RB
Biomed Pharmacother; 2018 Nov; 107():1763-1769. PubMed ID: 30257395
[TBL] [Abstract][Full Text] [Related]
35. MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1.
Gong Y; Wei ZR
BMC Cancer; 2022 Aug; 22(1):934. PubMed ID: 36038837
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
37. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
Zhu J; Liu F; Wu Q; Liu X
Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
[TBL] [Abstract][Full Text] [Related]
38. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
[TBL] [Abstract][Full Text] [Related]
39. LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis.
Li Y; Liu JJ; Zhou JH; Chen R; Cen CQ
Mol Med; 2020 Mar; 26(1):26. PubMed ID: 32188407
[TBL] [Abstract][Full Text] [Related]
40. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma.
Wu X; Xiang H; Cong W; Yang H; Zhang G; Wang Y; Guo Z; Shen Y; Chen B
Biochem Biophys Res Commun; 2020 Jun; 527(1):29-36. PubMed ID: 32446383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]